Ajanta Pharma Ltd.
| BSE: 532331 | Sector: Health care |
| NSE: AJANTPHARM | ISIN Code: INE031B01049 |
| BSE 11:39 | 25 May | 1698.80 |
-0.50 (-0.03%) |
OPEN
1703.35 |
HIGH
1703.35 |
LOW
1669.30 |
| NSE 11:29 | 25 May | 1701.50 |
1.10 (0.06%) |
OPEN
1709.30 |
HIGH
1709.30 |
LOW
1668.55 |
| OPEN | 1703.35 |
| PREVIOUS CLOSE | 1699.30 |
| VOLUME | 1509 |
| 52-Week high | 2420.00 |
| 52-Week low | 1593.30 |
| P/E | 20.16 |
| Mkt Cap.(Rs cr) | 14,508 |
| Buy Price | 1699.80 |
| Buy Qty | 1.00 |
| Sell Price | 1701.55 |
| Sell Qty | 10.00 |
Ajanta Pharma Ltd. (AJANTPHARM) - Company Information
Ajanta Pharma Ltd
Ajanta Pharma is a specialty pharmaceutical company engaged in development manufacture and marketing of quality finished dosages in domestic and international markets. The company produces a comprehensive range of specialty products targeting different therapeutic segments. The company's business includes Branded Generics in emerging markets of Asia and Africa Generics in the developed markets of ...> More
| COMPANY INFORMATION | |||||||
| Chairman : | Mannalal B Agrawal | ||||||
| Vice Chairman : | Madhusudan B Agrawal | ||||||
| Managing Director : | Yogesh Agrawal | ||||||
| Independent Director : | Chandrakanth M Khetan | ||||||
| Company Secretary : | Gaurang Shah | ||||||
| Joint Managing Director : | Rajesh M Agrawal | ||||||
| Independent Director : | K H Viswanathan | ||||||
| Independent Director : | Prabhakar Dalal | ||||||
| Independent Director : | Anjana Grewal | ||||||
| AUDITOR : | BSR & Co LLP | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| Ajanta House, Charkop Kandivli (W),Mumbai,Maharashtra-400067 | |||||||
| Ph : 91-22-66061000/1204/1203 | |||||||
| WEBSITE : http://www.ajantapharma.com | |||||||
| E-mail : info@ajantapharma.com | |||||||
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
